BRÈVE publiée le 11/07/2024 à 18:31, il y a 2 mois 9 jours Fuller, Smith & Turner PLC annonce une opération de rachat d'actions Actions Propres Rachat D'actions Bourse De Londres Fuller, Smith Et Turner Règle De Divulgation Et De Transparence
BRÈVE publiée le 11/07/2024 à 18:31, il y a 2 mois 9 jours Fuller, Smith & Turner PLC Announces Share Buyback Transaction London Stock Exchange Share Buyback Treasury Shares Disclosure And Transparency Rule Fuller, Smith & Turner
COMMUNIQUÉ DE PRESSE publié le 11/07/2024 à 18:26, il y a 2 mois 9 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 4,438 of its 'A' ordinary shares of 40p each on the London Stock Exchange as part of its buyback program London Stock Exchange Share Buyback Numis Securities Limited Fuller Smith Turner PLC Transaction
BRÈVE publiée le 10/07/2024 à 19:01, il y a 2 mois 10 jours Fuller, Smith & Turner PLC : Transaction sur actions propres Rachat D'actions Actions Ordinaires Règles De La FCA La Structure Du Capital Fuller
BRÈVE publiée le 10/07/2024 à 19:01, il y a 2 mois 10 jours Fuller, Smith & Turner PLC: Transaction in Own Shares Ordinary Shares Share Buyback FCA Rules Capital Structure Fuller’s
COMMUNIQUÉ DE PRESSE publié le 10/07/2024 à 18:56, il y a 2 mois 10 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 20,000 'A' ordinary shares as part of its share buyback program, with highest/lowest prices of 704.00 GBp per share Voting Rights London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited
BRÈVE publiée le 05/07/2024 à 18:21, il y a 2 mois 15 jours Fuller, Smith & Turner PLC: Transaction in Own Shares Voting Rights Ordinary Shares Share Buyback Treasury Shares Fuller Smith Turner
BRÈVE publiée le 05/07/2024 à 18:21, il y a 2 mois 15 jours Fuller, Smith & Turner PLC : Transaction sur actions propres Actions Propres Rachat D'actions Droit De Vote Actions Ordinaires Fuller Smith Turner
COMMUNIQUÉ DE PRESSE publié le 05/07/2024 à 18:16, il y a 2 mois 15 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 20,000 'A' ordinary shares at an average price of 701.00 GBp each as part of its share buyback programme London Stock Exchange Ordinary Shares Share Buyback Numis Securities Limited Fuller Smith Turner PLC
BRÈVE publiée le 03/07/2024 à 18:17, il y a 2 mois 17 jours Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Treasury Shares Fuller, Smith & Turner
Publié le 20/09/2024 à 17:40, il y a 8 heures 50 minutes Availability of the 2024 Half-Year Financial Report
Publié le 20/09/2024 à 17:40, il y a 8 heures 50 minutes Mise à disposition du Rapport Financier Semestriel 2024
Publié le 20/09/2024 à 23:40, il y a 2 heures 50 minutes Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Publié le 20/09/2024 à 23:30, il y a 3 heures Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Publié le 20/09/2024 à 23:00, il y a 3 heures 30 minutes AI/ML Innovations Inc. Provides Second Status Update
Publié le 20/09/2024 à 22:30, il y a 4 heures Electric Metals Announces Changes to its Board of Directors
Publié le 20/09/2024 à 22:15, il y a 4 heures 15 minutes Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Publié le 20/09/2024 à 22:58, il y a 3 heures 32 minutes Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Publié le 20/09/2024 à 21:00, il y a 5 heures 30 minutes Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Publié le 20/09/2024 à 20:14, il y a 6 heures 15 minutes EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Publié le 20/09/2024 à 19:50, il y a 6 heures 40 minutes BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Publié le 20/09/2024 à 19:47, il y a 6 heures 43 minutes EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma